News
AstraZeneca opens a $300 million cell therapy manufacturing facility in Rockville, boosting the local biotech industry.
A long-awaited trade deal has been struck between the UK and the US, but how much will FTSE 100 stocks benefit from the ...
Ministers are reviewing a controversial medicine tax that pharmaceutical companies say makes Britain 'uninvestable' as part ...
The Canadian Press on MSN12h
Today-History-May11Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content ...
Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases unit had hit the mark in a phase 3 trial, setting it on course for regulatory filings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results